Do sulphonylureas still have a place in clinical practice?

Sulphonylureas have been commercially available since the 1950s, but their use continues to be associated with controversy. Although adverse cardiovascular outcomes in some observational studies have raised concerns about sulphonylureas, findings from relatively recent, robust, and high-quality syst...

Celý popis

Podrobná bibliografie

Vydáno v:	The lancet. Diabetes & endocrinology Ročník 6; číslo 10; s. 821
Hlavní autoři:	Khunti, Kamlesh, Chatterjee, Sudesna, Gerstein, Hertzel C, Zoungas, Sophia, Davies, Melanie J
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England 01.10.2018
Témata:	Cardiovascular Diseases - chemically induced Cardiovascular Diseases - complications Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Humans Hypoglycemic Agents - adverse effects Randomized Controlled Trials as Topic Risk Factors Sulfonylurea Compounds - adverse effects Treatment Outcome
ISSN:	2213-8595, 2213-8595
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!